(Q51887666)

16 April 2018

title

The EBMT activity survey 2009: trends over the past 5 years. (English)

1 reference

16 April 2018

author name string

H Baldomero

1

1 reference

16 April 2018

M Gratwohl

2

1 reference

16 April 2018

A Gratwohl

3

1 reference

16 April 2018

A Tichelli

4

1 reference

16 April 2018

D Niederwieser

5

1 reference

16 April 2018

A Madrigal

6

1 reference

16 April 2018

K Frauendorfer

7

1 reference

16 April 2018

European Group for Blood and Marrow Transplantation EBMT

8

1 reference

16 April 2018

language of work or name

English

0 references

publication date

28 February 2011

1 reference

16 April 2018

Bone Marrow Transplantation

published in

1 reference

16 April 2018

volume

46

1 reference

16 April 2018

issue

4

1 reference

16 April 2018

page(s)

485-501

1 reference

16 April 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2011.11

exact match

0 references

cites work

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Hematopoietic-cell transplantation at 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Hematopoietic stem cell transplantation: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

The EBMT activity survey 2008: impact of team size, team density and new trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Predictability of hematopoietic stem cell transplantation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

A survey on cellular and engineered tissue therapies in europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Bone marrow transplantation for inherited bone marrow failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Reduced mortality after allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

Current trends in hematopoietic stem cell transplantation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

7 January 2021

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

7 January 2021

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

7 January 2021

The role of allogeneic-cell transplantation in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.11

7 January 2021

Identifiers

DOI

10.1038/BMT.2011.11

1 reference

16 April 2018

Dimensions Publication ID

1029965444

0 references

1 reference

16 April 2018